Roniciclib
Roniciclib (BAY 1000394) is a novel, orally bioavailable pan-cyclin-dependent kinase (CDK) inhibitor. It potently suppresses cell-cycle (CDK1/2/3/4) and transcriptional (CDK7/9) kinases with IC50 values of 5-25 nM. This small molecule is utilized in cancer research to study cell cycle arrest and apoptosis in both in vitro and in vivo models.
Product Specifications
CAS Number
1223498-69-8
Product Name Alternative
Cyclin dependent kinase, CDK7/Cyclin H/MAT1, CDK9/cyclin T1, CDK9/cyclinT1, CDK3/cyclinE, CDK4/cyclin D, CDK4/CyclinD, CDK2/cyclinE, CDK, CDK1/CyclinB, Cdk1/cyclin B, BAY 1000394, BAY1000394, BAY-1000394, inhibit, Inhibitor, Roniciclib
Field of Research
Cell Biology
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (11.62 mM) ; DMSO:249 mg/mL (578.48 mM)
Smiles
C[C@@H] (O) [C@@H] (C) Oc1nc (Nc2ccc (cc2) [S@] (=N) (=O) C2CC2) ncc1C (F) (F) F
Molecular Formula
C18H21F3N4O3S
Molecular Weight
430.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7191826 Inquire
Rabbit anti-Caenorhabditis elegans lbp-2 Polyclonal Antibody
Sign In for Pricing
View Details 
GTR10441104 96 Well
Canine RNA binding protein 38 (RBM38) ELISA kit
Sign In for Pricing
View Details 
K6194402 1.0 µg DNA
Ifltd1 sgRNA CRISPR Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details